Loading resource…

Eduardo Kattan, Miguel Ibarra-Estrada, Gustavo Ospina-Tascón, Glenn Hernández
The ANDROMEDA-SHOCK trial has positioned CRT assessment as a novel resuscitation target for septic shock. The article discusses the importance of peripheral perfusion assessment as a prognostic signal in critically ill patients, highlighting recent physiological studies that demonstrate the rapid improvement of CRT after interventions like fluid boluses. It emphasizes the potential diagnostic and therapeutic implications of CRT monitoring in septic shock and calls for future studies to confirm these findings and explore technological advancements in assessing peripheral perfusion.
No account needed